At the same time, our results found that the down-regulation of SAA1 enhanced sensitivity to TMZ chemotherapy in GBM, and SAA1 was closely related to IDH type, MGMT promoter methylation status and 1p / 19q co-deletion status. The gene discussed is SAA1; the disease is glioblastoma.